Lycopene intake and prostate cancer risk: Effect modification by plasma antioxidants and the XRCC1 genotype

Nutrition and Cancer

Volumn 55, Issue 1, 2006, Pages 13-20

  Goodman, Michael ^a   Bostick, Roberd M ^a   Ward, Kevin C ^a   Terry, Paul D ^a   Van Gils, Carla H ^b   Taylor, Jack A ^c   Mandel, Jack S ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; BETA CAROTENE; GLUTAMINE; LYCOPENE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; DIETARY INTAKE; FOOD FREQUENCY QUESTIONNAIRE; GENE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNITED STATES; XRCC1 GENE;

AGED; ALPHA-TOCOPHEROL; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BETA CAROTENE; CAROTENOIDS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODON; CONFIDENCE INTERVALS; DNA-BINDING PROTEINS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS;

EID: 33749183285     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5501_2     Document Type: Article

References (57)

1. Lu Q, Hung J, Heber D, Go V, Reuter V, et al.: Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev 10, 749-756, 2001.
2. Heber D and Lu Q: Overview of mechanisms of action of lycopene. Exp Biol Med 227, 920-923, 2002.
3. Pohar K, Gong M, Bahnson R, Miller E, and Clinton S: Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer. World J Urol 21, 9-14, 2003.
4. Kaplan L, Lau J, and Stein E: Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem 8, 1-10, 1990.
5. Nierenberg D and Nann S: A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr 56, 417-426, 1992.
6. Giovannucci E: Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr 135, S2030-S2031, 2005.
7. Giovannucci E: A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med 227, 852-859, 2002.
8. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, et al.: Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59, 1225-1230, 1999.
9. Hsing A, Comstock G, Abbey H, and Polk B: Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. JNCI 82, 941-946, 1990.
10. Nomura A, Stemmermann G, Lee J, and Craft N: Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6, 487-491, 1997.
11. Kirsh V, Mayne S, Peters U, Chatterjee N, Leitzmann M, et al.: A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15, 92-98, 2006.
12. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, and Willett WC: A prospective study of tomato products, lycopene, and prostate cancer risk. JNCI 94, 391-398, 2002.
13. Mills P, Beeson W, Phillips R, and Fraser G: Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64, 598-604, 1989.
14. Schuurman A, Goldbohm R, Dorant E, and van den Brandt P: Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev 7, 673-680, 1998.
15. Kolonel L, Hankin J, Whittemore A, Wu A, Gallagher R, et al.: Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9, 795-804, 2000.
16. Schuman L, Mandel J, Radke A, Seal U, and Halberg F: Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul case-control study. In Trends in Cancer Incidence, Magnus K (ed). Oslo, Norway: IUCC, 1981.
17. Tzonou A, Signorello L, Lagiou P, Wuu J, Trichopoulos D, et al.: Diet and cancer of the prostate: a case-control study in Greece. Int J Cancer 80, 704-708, 1999.
18. Le Marchand L, Hankin J, Kolonel L, and Wilkens L: Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 133, 215-219, 1991.
19. Wu K, Erdman J, Schwartz S, Platz E, Leitzmann M, et al.: Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 13, 260-269, 2004.
20. Etminan M, Takkouche B, and Caamano-Isorna F: The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 13, 340-345, 2004.
21. Stahl W, Junghans A, de Boer B, Driomina E, Briviba K, et al.: Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein. FEBS Lett 427, 305-308, 1998.
22. Li H, Kantoff P, Giovannucci E, Leitzmann M, Gaziano J, et al.: Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 65, 2498-2504, 2005.
23. Lu A, Li X, Gu Y, Wright P, and Chang D: Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys 35, 141-170, 2001.
24. Goode E, Ulrich C, and Potter J: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11, 1513-1530, 2002.
25. van Gils C, Bostick R, Stern M, and Taylor J: Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev 11, 1279-1284, 2002.
26. Boiteux S and Radicella J: The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377, 1-8, 2000.
27. Savas S, Kim D, Ahmad M, Shariff M, and Ozcelik H: Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol Biomarkers Prev 13, 801-807, 2004.
28. Chen L, Ambrosone C, Lee J, Sellers T, Pow-Sang J, et al.: Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol 175, 108-112, 2006.
29. Rybicki B, Conti D, Moreira A, Cicek M, Casey G, et al.: DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13, 23-29, 2004.
30. Patel A, Calle E, Pavluck A, Feigelson H, Thun M, et al.: A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res 7, R1168-R1173, 2005.
31. Kelsey K, Park S, Nelson H, and Karagas M: A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 13, 1337-1341, 2004.
32. Andrew A, Nelson H, Kelsey K, Moore J, Meng A, et al.: Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking, and bladder cancer susceptibility. Carcinogenesis 27, 1030-1037, 2006.
33. Blazer D, Umbach D, Bostick R, and Taylor J: Vitamin D receptor polymorphisms and prostate cancer. Mol Carcinog 27, 18-23, 2000.
34. Mangels A, Holden J, Beecher G, Forman M, and Lanza E: Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 93, 284-296, 1993.
35. Block G, Dresser C, Hartman A, and Carroll M: Nutrient sources in the American diet: quantitative data from the NHANES II survey. II. Macronutrients and fats. Am J Epidemiol 122, 27-40, 1985.
36. De Leenheer A, De Bevere V, De Ruyter M, and Claeys A: Simultaneous determination of retinol and α-tocopherol in human serum by high-performance liquid chromatography. J Chromatogr 162, 408-413, 1979.
37. Bieri J, Brown E, and Smith J: Determination of individual carotenoids in human plasma by high performance chromatography. J Liquid Chromatogr 8, 473-484, 1985.
38. Lunn R, Langlois R, Hsieh L, Thompson C, and Bell D: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59, 2557-2561, 1999.
39. Kleinbaum D and Klein M: Logistic Regression: A Self-Learning Text. New York: Springer-Verlag, 2002.
40. Virtamo J, Pietinen P, Huttunen J, Korhonen P, Malila N, et al.: Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 290, 476-485, 2003.
41. Rautalahti M, Albanes D, Virtamo J, Taylor P, Huttunen J, et al.: Beta-carotene did not work: aftermath of the ATBC study. Cancer Lett 114, 235-236, 1997.
42. Stanner S, Hughes J, Kelly C, and Buttriss J: A review of the epidemiological evidence for the "antioxidant hypothesis." Public Health Nutr 7, 407-422, 2004.
43. Seifried H, McDonald S, Anderson D, Greenwald P, and Milner J: The antioxidant conundrum in cancer. Cancer Res 63, 4295-4298, 2003.
44. Liu R: Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134, S3479-S3485, 2004.
45. Krinsky N and Deneke S: Interaction of oxygen and oxy-radicals with carotenoids. JNCI 69, 205-210, 1982.
46. Micozzi M, Beecher G, Taylor P, and Khachik F: Carotenoid analyses of selected raw and cooked foods associated with a lower risk for cancer. JNCI 82, 282-285, 1990.
47. Britton G: Structure and properties of carotenoids in relation to function. FASEB J 9, 1551-1558, 1995.
48. Nishino H, Tokuda H, Murakoshi M, Satomi Y, Masuda M, et al.: Cancer prevention by natural carotenoids. Biofactors 13, 89-94, 2000.
49. Hennekens C, Buring J, Manson J, Stampfer M, Rosner B, et al.: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149, 1996.
50. Wang Y, Spitz M, Zhu Y, Dong Q, Shete S, et al.: From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2, 901-908, 2003.
51. Hung R, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, et al.: Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. JNCI 97, 567-576, 2005.
52. Matullo G, Dunning A, Guarrera S, Baynes C, Polidoro S, et al.: DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27, 997-1007, 2006.
53. Hung R, Hall J, Brennan P, and Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162, 925-942, 2005.
54. Sies H: Oxidative Stress. London: Academic Press, 1985.
55. Lear J, Smith A, Strange R, and Fryer A: Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy. Br J Dermatol 142, 8-15, 2000.
56. Nelson W, DeWeese T, and DeMarzo A: The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev 21, 3-16, 2002.
57. National Cancer Institute: Cancer Genome Anatomy Project: SNP500Cancer Database, Bethesda, MD, 2004.